Biocodex

Free public records show Biocodex in 1 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by Biocodex or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on Biocodex

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Home country
France
Legal name
BIOCODEX
Type
Medicines

Source: Wikidata, Company record Q126879109. Retrieved 13 Nov 2026.

Source: GLEIF, Legal entity record, LEI 969500JRK0RE7CYZSO20. Retrieved 13 Nov 2026.

Trials over time

Studies Biocodex leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with Biocodex or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show Biocodex: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Healthcare Topics

The topics of the markets Biocodex is in.

All healthcare topics

Search all reports for Biocodex All companies